<?xml version="1.0" encoding="UTF-8"?>
<ref id="rmv1978-bib-0142">
 <label>142</label>
 <mixed-citation publication-type="journal" id="rmv1978-cit-0143">
  <string-name>
   <surname>Ramsauer</surname>
   <given-names>K</given-names>
  </string-name>, 
  <string-name>
   <surname>Schwameis</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Firbas</surname>
   <given-names>C</given-names>
  </string-name>, et al. 
  <article-title>Immunogenicity, safety, and tolerability of a recombinant measles‐virus‐based chikungunya vaccine: a randomised, double‐blind, placebo‐controlled, active‐comparator, first‐in‐man trial</article-title>. 
  <source xml:lang="en">Lancet Infect Dis</source>. 
  <year>2015</year>;
  <volume>15</volume>(
  <issue>5</issue>):
  <fpage>519</fpage>‐
  <lpage>527</lpage>.
  <pub-id pub-id-type="pmid">25739878</pub-id>
 </mixed-citation>
</ref>
